[Side effects of neuroleptics in compound preparations].
D000328:Adult; D002074:Butanones / Q000009:adverse effects; D003863:Depression / Q000209:etiology; D004304:Dosage Forms; D004338:Drug Combinations; D004958:Estradiol / Q000008:administration & dosage / Q000009:adverse effects; D005116:Extrapyramidal Tracts / Q000187:drug effects; D005260:Female; D006801:Humans; D008134:Long-Term Care; D008875:Middle Aged; D009069:Movement Disorders / Q000209:etiology; D010276:Parasympatholytics / Q000008:administration & dosage / Q000009:adverse effects; D011374:Progesterone / Q000008:administration & dosage / Q000009:adverse effects; D000644:Quaternary Ammonium Compounds / Q000009:adverse effects; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000494:pharmacology; D014268:Trifluoperazine / Q000008:administration & dosage / Q000009:adverse effects
D002074:Butanones; D004304:Dosage Forms; D004338:Drug Combinations; D010276:Parasympatholytics; D000644:Quaternary Ammonium Compounds; D014149:Tranquilizing Agents; D014268:Trifluoperazine; D011374:Progesterone; D004958:Estradiol
Unerwünschte Wirkungen bei Behandlung mit Neuroleptika in Kombinationspräparaten.